Michael A Carducci

Professor

19952018
If you made any changes in Pure these will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 3 Similar Profiles
Prostatic Neoplasms Medicine & Life Sciences
docetaxel Medicine & Life Sciences
Castration Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Prostate-Specific Antigen Medicine & Life Sciences
Androgens Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Renal Cell Carcinoma Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1995 2018

A phase 1, first-in-human study of AMG 900, an orally administered pan-Aurora kinase inhibitor, in adult patients with advanced solid tumors

Carducci, M., Shaheen, M., Markman, B., Hurvitz, S., Mahadevan, D., Kotasek, D., Goodman, O. B., Rasmussen, E., Chow, V., Juan, G., Friberg, G. R., Gamelin, E., Vogl, F. D. & Desai, J., Jul 7 2018, (Accepted/In press) In : Investigational New Drugs. p. 1-12 12 p.

Research output: Contribution to journalArticle

Aurora Kinases
Granulocyte Colony-Stimulating Factor
Maximum Tolerated Dose
Ovarian Neoplasms
Triple Negative Breast Neoplasms

Bone turnover biomarkers identify unique prognostic risk groups in men with castration resistant prostate cancer and skeletal metastases: Results from SWOG S0421

Lara, P. N., Plets, M., Tangen, C., Gertz, E., Vogelzang, N. J., Hussain, M., Twardowski, P. W., Garzotto, M. G., Monk, J. P., Carducci, M., Goldkorn, A., Mack, P. C., Thompson, I., Van Loan, M. & Quinn, D. I., Jan 1 2018, In : Cancer Treatment and Research Communications. 16, p. 18-23 6 p.

Research output: Contribution to journalArticle

bis(2,3,3,3-tetrachloropropyl) ether
Bone Remodeling
Castration
Prostatic Neoplasms
Biomarkers

Burden of Metastatic Castrate Naive Prostate Cancer Patients, to Identify Men More Likely to Benefit from Early Docetaxel: Further Analyses of CHAARTED and GETUG-AFU15 Studies

Gravis, G., Boher, J. M., Chen, Y. H., Liu, G., Fizazi, K., Carducci, M. A., Oudard, S., Joly, F., Jarrard, D. M., Soulie, M., Eisenberger, M. J., Habibian, M., Dreicer, R., Garcia, J. A., Hussain, M. H. M., Kohli, M., Vogelzang, N. J., Picus, J., DiPaola, R. & Sweeney, C., Jan 1 2018, (Accepted/In press) In : European Urology.

Research output: Contribution to journalArticle

docetaxel
Prostatic Neoplasms
Androgens
Survival
Therapeutics

Muscadine grape skin extract (MPX) in men with biochemically recurrent prostate cancer: A randomized, multicenter, placebo-controlled clinical trial

Paller, C. J. , Zhou, X. C. , Heath, E. I. , Taplin, M. E. , Mayer, T. , Stein, M. N. , Bubley, G. J. , Pili, R. , Hudson, T. , Kakarla, R. , Abbas, M. M. , Anders, N. M. , Dowling, D. , King, S. , Bruns, A. B. , Wagner, W. D. , Drake, C. G. , Antonarakis, E. S. , Eisenberger, M. A. , Denmeade, S. R. & 3 others Rudek, M. A., Rosner, G. L. & Carducci, M. A., Jan 15 2018, In : Clinical Cancer Research. 24, 2, p. 306-315 10 p.

Research output: Contribution to journalArticle

Controlled Clinical Trials
Vitis
Prostatic Neoplasms
Placebos
Skin

Naming disease states for clinical utility in prostate cancer: A rose by any other name might not smell as sweet

Armstrong, A. J. , Antonarakis, E. S. , Taplin, M. E. , Kelly, W. K. , Beltran, H. , Fizazi, K. , Dahut, W. L. , Shore, N. , Slovin, S. , George, D. , Carducci, M. A. , Corn, P. , Danila, D. , Dreicer, R. , Heath, E. , Rathkopf, D. , Liu, G. , Nanus, D. , Stein, M. , Smith, M. R. & 12 others Sternberg, C., Wilding, G., Nelson, P. S., Halabi, S., Kantoff, P., Clarke, N. W., Evans, C. P., Heidenreich, A., Mottet, N., Gleave, M., Morris, M. J. & Scher, H. I., Jan 1 2018, In : Annals of Oncology. 29, 1, p. 23-25 3 p., mdx648

Research output: Contribution to journalEditorial

Smell
Prostatic Neoplasms